Below is a recap of research funding opportunitiesthat were recently announced, nationwide. While these alerts are intended to provide you with a broad-reaching overview of the opportunities available, we certainly want to hear if thereare specific opportunities that you would like to pursue. Please let your Content Director know if you have any questions or are interested in learning more.
Our Grant Alerts dashboard profiles relevant previously announced national-level funding opportunities, which can be sorted by type, agency/funder, and date. Also, your dedicated Content Director and Relationship Director are ready to help with custom research solutions to the challenges you are facing.
Quick Links to Opportunities
These links will take you directly to the websites of the grant opportunities.
This program encourages clinical trials to establish the effectiveness and test hypotheses regarding mechanisms of action, mediators, and predictors and moderators of post-acute phase therapeutic and services interventions that are matched to the stage of illness in terms of both their focus (e.g., consolidating and maintaining gains from initial treatment, managing residual symptoms/impairment, preventing relapse, promoting adherence and appropriate service use) and intensity/burden for promoting optimal longer-term outcomes.
This program aims to encourage applications that focus on understanding bidirectional relationships between social media use and adolescent mental illness, psychiatric symptoms, and risk or resilience for psychopathology, as well as social media as a platform for facilitating the identification of adolescents with or at risk for mental illness, for encouraging appropriate mental health service use, and for delivering preventive and therapeutic interventions.
This program encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states.
This program invites R01 grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of these modalities in the characterization of therapy response and/or emergence of treatment resistance.
This program aims to encourage investigators to pursue translational activities and small clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. Activities supported in this program include regulatory activities to obtain an Investigational Device Exemption for a Significant Risk study, as well as a subsequent small clinical study.
Eligibility:
There are no eligibility restrictions.
Dates:
LOIs 60 days before deadlines; final deadline is September 28, 2026.
This program intends to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cancer-related health behaviors, screening, early detection, healthcare delivery, management of treatment-related symptoms, supportive care, and the long-term outcomes of cancer survivors.
This program encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, digital health and data science, and implementation science.
This program is intended to support the development of digital health test beds that leverage well-established digital health platforms and infrastructure to rapidly refine and optimize existing evidence-based digital health interventions and to conduct clinical research testing digital mental health interventions that are statistically powered to provide a definitive answer regarding the intervention's effectiveness particularly in populations who experience health disparities and vulnerable populations.
This program aims to support innovative research that will inform our understanding of the mechanisms underlying the formation of structural birth defects using animal models in conjunction with human translational/clinical approaches. Applicants are encouraged to take advantage of advances in genetics, ‘omics methods (genomics, proteomics, metabolomics, etc.), and synthetic biology, biochemical and other approaches to developmental biology research to identify specific genetic, epigenetic, environmental, or gene/environment interactions associated with the formation of, susceptibility to, and variability of structural birth defects in human populations.
This program invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography or single photon emission computed tomography for molecular targets (e.g., receptors, intracellular messengers, disease-related proteins) that are implicated in brain disorders as tools to study disease pathophysiology and/or for assessing target engagement of potential therapeutic candidates. The objective of this NOFO is to stimulate research in the identification and development of PET and SPECT probes for disorders of primary interest to the NIMH or NIA.
This program is intended to promote innovative, high-quality nonmalignant hematology research relevant to the missions of various NIH ICs. Investigator-initiated research project grant applications in specific areas of basic and early translational hematology research are invited to this program that supports growth in the non-malignant hematology research domain.
This program encourages submission of projects devoted to demonstrating that mammalian models, including organoids, tumoroids and cell models, used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patient benefit. These practical goals contrast with the goals of many mechanistic, NCI-supported R01 projects that use mammals, or develop and use mammalian cancer models, transplantation tumor models, or models derived from mammalian or human tissues or cells for hypothesis-testing, non-clinical research.
This program aims to promote broad participation in biomedical research by supporting resource-limited institutions to conduct research, enhance their research environments, and increase sponsored programs administration capacity.
NLM wishes to accelerate access to, and availability of, secure, complete datasets and computational models that can serve as the basis for transformative biomedical discoveries. Innovative at-scale computational approaches that increase the speed and scope of curation processes are needed for data mining and knowledge discovery from growing quantities of biomedical data being produced from ongoing data science advances.
This program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-priced, specialized, commercially available instruments or integrated instrumentation system. The minimum award is $50,000. There is no maximum price limit for the instrument; however, the maximum award is $750,000. Instruments supported include, but are not limited to: light microscopes, biomedical imagers, mass spectrometers, nuclear magnetic resonance spectrometers, flow cytometers, DNA and protein sequencers, biosensors, and X-ray diffractometers.
The motivation for this program is the recognition that much of the current imaging research on inflammation in cancer relies heavily on in vitro and ex vivo methods. These approaches have limited potential to provide significant insights into the dynamic interactions between cancer and inflammation; utilizing molecular imaging probes in pre-clinical and clinical investigations allows for precise temporal resolution at molecular and cellular levels.
The ReWARD program provides support for the health-related research of scientists who are making a significant contribution to Diversity, Equity, Inclusion, and Accessibility and who have no current NIH research project grant funding. The ReWARD program provides funding for both the scientific research and the DEIA activities of investigators. The grant will support scientific research in areas related to the programmatic interests of one or more of the participating ICs and DEIA activities focused on enhancing diversity in the biomedical research enterprise within the United States and territories.
This program encourages applications that will expand knowledge of the natural history of disorders that currently are, or may become, part of statewide newborn screening programs. A comprehensive understanding of the natural history of a condition is necessary to facilitate appropriate interventions for infants identified by newborn screening. Characterization of the sequence and timing of symptom development provides information crucial for developing targeted, age-appropriate treatments and for establishing a baseline against which to assess novel interventions.
This program solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies.
This program aims to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a “hit” is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays.
This program intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, or treatment of cancer. A distinguishing feature of each application to this NOFO will be formation of an academic-industrial partnership: a strategic alliance of academic and industrial investigators who work together as partners to identify and translate a technological solution for mitigation of a cancer (or other disease-related) problem.
This program seeks to stimulate the development of innovative mathematical theories, techniques, and approaches to investigate challenging questions of great interest to biologists and public health policymakers. It supports truly integrative research projects in mathematical biology that address challenging and significant biological questions through novel applications of traditional, but nontrivial, mathematical tools and methods or the development of new mathematical theories.
This program supports fundamental research and research capacity across disciplines at MSIs and encourages research collaborations with scholars at MSIs. Growing the STEM workforce is a national priority. National forecasts of the impending shortage of workers with science and engineering skills and essential research workers underscore a need to expand opportunities to participate in STEM research.
The Precision Measurement Grant Program is seeking applications from eligible applicants for research work in the field of fundamental measurement, testing the basic laws of physics, and/or the determination of fundamental constants, with emphasis on pressing problems or emerging opportunities.
ASR supports research on key cloud, aerosol, precipitation, and radiative transfer processes that affect the Earth’s radiative balance and hydrological cycle, especially processes that limit the predictive ability of regional and global models. This NOFO solicits research grant applications for observational, data analysis, and/or modeling studies that use BER-supported Atmospheric Radiation Measurement user facility observations to improve understanding and model representation of (1) Atmospheric processes from ARM’s Coast-Urban-Rural Atmospheric Gradient Experiment and (2) high latitude and Southern Ocean atmospheric processes using ARM observations.
This program will consider applications that focus on measurements, experiments, field data, modeling, and synthesis to provide improved understanding and representation of ecosystems and watersheds in ways that advance the sophistication and capabilities of models that span from individual processes to Earth-system scales.
The goal of this program is to develop neutrino detectors with greatly increased performance for detection of neutrinos from sources such as nuclear reactors and nuclear materials. Detectors will make use of neutrino/matter interactions that produce low energy nuclear recoils and athermal phonons in absorber materials with high neutron numbers at the (multi)-kilogram scale. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice.
The Foundation invites applications for the 2025 Young Investigator Grant program, which awards a Young Investigator grant designed to support early career researchers, such as postdoctoral fellows, clinical fellows, or instructors, pursuing promising childhood cancer research ideas. These grants aim to cultivate the best and brightest researchers of the future who demonstrate a commitment to a research career in pediatric cancer. A mentor is required, and a career development plan must be included. The grant provides up to $60,000 in direct costs per year for three years.
The Foundation solicits applications for academic investigators conducting research to demonstrate the benefits of novel ways to access or deliver mental health care or prevention approaches that can be implemented at scale. This application is specifically for high-quality research that builds on promising pilot work and will lead to a larger demonstration project.
The second phase of funding seeks to continue the momentum initiated by the Reimagining Nursing Initiative’s first round of nurse-led pilot programs to support solutions that positively transform health care through the adoption of approaches, tools, and practices that improve access, quality care, and positive patient outcomes. The grant will support nurse-led research and promote health equity and nurse well-being. With this in mind, grantees will be solicited to examine the intersection of the program’s three areas of focus including nursing education, direct reimbursement, and nurse-driven technology in order to scale and implement effective nurse-led solutions.
This fund invites proposals to encourage exploratory and developmental Alzheimer’s disease research projects within the United States by providing support for the early and conceptual plans of projects that may not yet be supported by extensive preliminary data but have the potential to substantially advance biomedical research. Proposals should be distinct from projects designed to increase knowledge in a well-established area unless it is intended to extend previous discoveries toward new directions or applications. Applications may encompass a project period of up to two years with a combined budget for direct costs up to $500,000.
Robert H. N. Ho Family Foundation Translation Grants in Buddhist Studies will award grants of up to $50,000 to support translations of important Buddhist texts for the benefit of contemporary audiences (e.g., communities of scholarship and Buddhist practice) who currently do not have access to them in their own languages. Applicants may propose the translation of works from any genre of Buddhist literature from any period and region.
Eligibility:
There are no eligibility restrictions.
Dates:
Proposals are due by December 3, 2024.
Questions?
We'll be happy to help you find the right grants opportunity for your organization.
About Hanover Research: Founded in 2003, Hanover Research is a global research and grant development firm. The Hanover Grants practice provides research development, grant writing, and strategic advising support to a wide range of institutions and organizations. Our professionals deliver customized proposal review, revision, and production support, while also helping to align strategic priorities to funding trends and opportunities at all levels. To learn more about Hanover Research, visit www.hanoverresearch.com.
Hanover Research 4401 Wilson Blvd, 4th Floor Arlington VA 22203
You received this email because you are subscribed to Grant Alerts and Calendars from Hanover Research.
Update your email preferences to choose the types of emails you receive.
